MEG3 and breast cancer: Furthermore, lower expression of MEG3 was correlated to poor prognosis when the recurrence-free survival of breast cancer was assayed using Kaplan-Meier Plotter database [35] (HR = 0.76 (0.69–0.85), p = 1.8e-07) (Fig. 1B).